Search research articles
Contact Us
Filters
Showing results (101-110 of 311) with videos related to
Page
of 32
Sort By:
Critical Reviews in Oncology/Hematology
|
September 7, 2010
Prevention and management of major side effects of targeted agents in breast cancer
Otto Metzger Filho, Kamal S Saini, Hatem A Azim, et al.
Investigational New Drugs
|
March 15, 2012
Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad?
Andrea Gombos, Otto Metzger-Filho, Lissandra Dal Lago, et al.
Coronary Artery Disease
|
May 27, 2025
Recurrent coronary in-stent restenosis and rapidly progressive coronary artery disease as initial manifestation of immunoglobulin G4-related disease
Georgiana Pintea Bentea, Ahmad Awada, Vanessa Mary Crapanzano Minichello, et al.
Cancer Treatment Reviews
|
March 19, 2022
Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era
Jaume Capdevila, Ahmad Awada, Dagmar Führer-Sakel, et al.
Ecancermedicalscience
|
January 26, 2019
Precision oncology: as much expectations as limitations
Vitor Fiorin Vasconcellos, Leandro Machado Colli, Ahmad Awada, et al.
The Oncologist
|
January 1, 2008
Review: side effects of approved molecular targeted therapies in solid cancers
Christian Widakowich, Gilberto de Castro, Evandro de Azambuja, et al.
ESMO Open
|
June 4, 2020
Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity
Dan Engelman, Michel Moreau, Antonia Lepida, et al.
ESMO Open
|
December 5, 2019
CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an <i>ESMO Open-Cancer Horizons</i> pro and con discussion
Ahmad Awada, Joseph Gligorov, Guy Jerusalem, et al.
Head & Neck
|
October 22, 2014
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer
Yassine Lalami, Camillo Garcia, Patrick Flamen, et al.
Cancer Treatment Reviews
|
October 2, 2007
Novel cytotoxic drugs: old challenges, new solutions
Gustavo F V Ismael, Daniela Dornelles Rosa, Max S Mano, et al.
Page
of 32
Search research articles
Search
Showing results (101-110 of 311) with videos related to
Sort By:
Page
of 32
Critical Reviews in Oncology/Hematology
|
September 7, 2010
Prevention and management of major side effects of targeted agents in breast cancer
Otto Metzger Filho, Kamal S Saini, Hatem A Azim, et al.
Investigational New Drugs
|
March 15, 2012
Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad?
Andrea Gombos, Otto Metzger-Filho, Lissandra Dal Lago, et al.
Coronary Artery Disease
|
May 27, 2025
Recurrent coronary in-stent restenosis and rapidly progressive coronary artery disease as initial manifestation of immunoglobulin G4-related disease
Georgiana Pintea Bentea, Ahmad Awada, Vanessa Mary Crapanzano Minichello, et al.
Cancer Treatment Reviews
|
March 19, 2022
Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era
Jaume Capdevila, Ahmad Awada, Dagmar Führer-Sakel, et al.
Ecancermedicalscience
|
January 26, 2019
Precision oncology: as much expectations as limitations
Vitor Fiorin Vasconcellos, Leandro Machado Colli, Ahmad Awada, et al.
The Oncologist
|
January 1, 2008
Review: side effects of approved molecular targeted therapies in solid cancers
Christian Widakowich, Gilberto de Castro, Evandro de Azambuja, et al.
ESMO Open
|
June 4, 2020
Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity
Dan Engelman, Michel Moreau, Antonia Lepida, et al.
ESMO Open
|
December 5, 2019
CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an <i>ESMO Open-Cancer Horizons</i> pro and con discussion
Ahmad Awada, Joseph Gligorov, Guy Jerusalem, et al.
Head & Neck
|
October 22, 2014
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer
Yassine Lalami, Camillo Garcia, Patrick Flamen, et al.
Cancer Treatment Reviews
|
October 2, 2007
Novel cytotoxic drugs: old challenges, new solutions
Gustavo F V Ismael, Daniela Dornelles Rosa, Max S Mano, et al.
Page
of 32